Citation Impact
Citing Papers
Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector
2006 StandoutNobel
Effective treatment of severe COVID-19 patients with tocilizumab
2020 Standout
Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis
2014
Distinct fibroblast lineages determine dermal architecture in skin development and repair
2013 StandoutNature
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo‐controlled phase I/II trial of CAT‐192
2006
Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis
2011
Systemic Sclerosis Sine Scleroderma: A Multicenter Study of 1417 Subjects
2014
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2008 Standout
Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease
2011
Rheumatoid arthritis
2016 Standout
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database
2014
Why Most Published Research Findings Are False
2005 Standout
Multistage Nanoparticles for Improved Delivery into Tumor Tissue
2012 StandoutNobel
The assessment of the patient with systemic sclerosis
2003
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Drug penetration in solid tumours
2006 Standout
Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers
2002
Cancer Metastasis: Building a Framework
2006 Standout
Prevalence and clinical correlates of pruritus in patients with systemic sclerosis: an updated analysis of 959 patients
2013
Digital ulcers predict a worse disease course in patients with systemic sclerosis
2015
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
2014 Standout
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial
1999
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database
2015
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards
2014
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Relaxin: a pregnancy hormone as central player of body fluid and circulation homeostasis
2003
Pathogenesis and management of pain in osteoarthritis
2005
Systemic sclerosis
2017 Standout
Seventeen-point dermal ultrasound scoring system--a reliable measure of skin thickness in patients with systemic sclerosis
2003
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo
2005 StandoutNobel
Osteoarthritis
2015 Standout
IL-6 as a keystone cytokine in health and disease
2015 Standout
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
2010 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
2010
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
Ankylosing spondylitis
2007 Standout
The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma
2004
The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway
2005 Standout
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis
2013
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Inhibition of markers of hepatic stellate cell activation by the hormone relaxin
2003
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
2011
Nutritional status measured by BMI is impaired and correlates with left ventricular mass in patients with systemic sclerosis
2014
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblasts
2007 StandoutNobel
Rheumatic diseases: the effects of inflammation on bone
2005
Idiopathic Pulmonary Fibrosis
2001 Standout
Microenvironmental regulation of metastasis
2008 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Therapeutic strategies for rheumatoid arthritis
2003
Revised Estimates for the Number of Human and Bacteria Cells in the Body
2016 Standout
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation
2003
Observational Study of Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis
2009
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Biomarkers for epithelial-mesenchymal transitions
2009 Standout
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Fibroblasts in cancer
2006 Standout
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
2012 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Systemic sclerosis: hypothesis-driven treatment strategies
2006
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
2015
Systemic sclerosis
2015
Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration
2008 Standout
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
2004
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
2010 Standout
β-Arrestin Deficiency Protects Against Pulmonary Fibrosis in Mice and Prevents Fibroblast Invasion of Extracellular Matrix
2011 StandoutNobel
Therapeutic coronary angiogenesis: a fronte praecipitium a tergo lupi?
2001
Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
2003 StandoutNobel
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer
2006
Works of Michael Weisman being referenced
Recombinant Human Relaxin in the Treatment of Scleroderma
2000
Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis
2001
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.
1995
Bone mineral density and clinical hand osteoarthritis in elderly men and women: the Rancho Bernardo study.
2002
Recombinant Human Relaxin in the Treatment of Scleroderma
2000